RMD
Price
$263.03
Change
+$11.62 (+4.62%)
Updated
Feb 4 closing price
Capitalization
38.32B
77 days until earnings call
Intraday BUY SELL Signals
SOLV
Price
$76.49
Change
+$0.74 (+0.98%)
Updated
Feb 4 closing price
Capitalization
13.27B
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RMD vs SOLV

Header iconRMD vs SOLV Comparison
Open Charts RMD vs SOLVBanner chart's image
ResMed
Price$263.03
Change+$11.62 (+4.62%)
Volume$1.73M
Capitalization38.32B
Solventum
Price$76.49
Change+$0.74 (+0.98%)
Volume$1.56M
Capitalization13.27B
RMD vs SOLV Comparison Chart in %
RMD
Daily Signal:
Gain/Loss:
SOLV
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RMD vs. SOLV commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMD is a Hold and SOLV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (RMD: $263.03 vs. SOLV: $76.49)
Brand notoriety: RMD and SOLV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RMD: 172% vs. SOLV: 151%
Market capitalization -- RMD: $38.32B vs. SOLV: $13.27B
RMD [@Pharmaceuticals: Other] is valued at $38.32B. SOLV’s [@Pharmaceuticals: Other] market capitalization is $13.27B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RMD’s FA Score shows that 0 FA rating(s) are green whileSOLV’s FA Score has 1 green FA rating(s).

  • RMD’s FA Score: 0 green, 5 red.
  • SOLV’s FA Score: 1 green, 4 red.
According to our system of comparison, RMD is a better buy in the long-term than SOLV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RMD’s TA Score shows that 6 TA indicator(s) are bullish while SOLV’s TA Score has 3 bullish TA indicator(s).

  • RMD’s TA Score: 6 bullish, 4 bearish.
  • SOLV’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, RMD is a better buy in the short-term than SOLV.

Price Growth

RMD (@Pharmaceuticals: Other) experienced а +2.06% price change this week, while SOLV (@Pharmaceuticals: Other) price change was -0.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.79%. For the same industry, the average monthly price growth was -0.75%, and the average quarterly price growth was +22.77%.

Reported Earning Dates

RMD is expected to report earnings on Apr 23, 2026.

SOLV is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-1.79% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($38.3B) has a higher market cap than SOLV($13.3B). RMD has higher P/E ratio than SOLV: RMD (26.02) vs SOLV (8.78). RMD YTD gains are higher at: 9.200 vs. SOLV (-3.470). SOLV has higher annual earnings (EBITDA): 2.59B vs. RMD (2B). SOLV has more cash in the bank: 1.64B vs. RMD (1.38B). RMD has less debt than SOLV: RMD (846M) vs SOLV (5.14B). SOLV has higher revenues than RMD: SOLV (8.4B) vs RMD (5.26B).
RMDSOLVRMD / SOLV
Capitalization38.3B13.3B288%
EBITDA2B2.59B77%
Gain YTD9.200-3.470-265%
P/E Ratio26.028.78296%
Revenue5.26B8.4B63%
Total Cash1.38B1.64B84%
Total Debt846M5.14B16%
FUNDAMENTALS RATINGS
RMD: Fundamental Ratings
RMD
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
36
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RMDSOLV
RSI
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
63%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
56%
MACD
ODDS (%)
Bullish Trend 1 day ago
54%
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 9 days ago
62%
Bullish Trend 22 days ago
63%
Declines
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
46%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
RMD
Daily Signal:
Gain/Loss:
SOLV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IFLO30.290.34
+1.14%
VictoryShares Intl Free Csh Flow ETF
QDEF82.610.24
+0.29%
FlexShares Quality Dividend Defensv ETF
TDSC26.15-0.03
-0.13%
ETC Cabana Target Drawdown 10 ETF
SJNK25.25-0.04
-0.16%
State Street® SPDR® Blmbg ST HY Bd ETF
EPV19.80-0.08
-0.41%
ProShares UltraShort FTSE Europe

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with BLFS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then BLFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+4.62%
BLFS - RMD
44%
Loosely correlated
-0.74%
SMTI - RMD
43%
Loosely correlated
+0.92%
SOLV - RMD
40%
Loosely correlated
+0.98%
RVTY - RMD
40%
Loosely correlated
+2.67%
SYK - RMD
39%
Loosely correlated
-0.04%
More

SOLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with NVST. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
+0.98%
NVST - SOLV
57%
Loosely correlated
+3.27%
XRAY - SOLV
53%
Loosely correlated
+4.50%
RMD - SOLV
52%
Loosely correlated
+4.62%
ALC - SOLV
46%
Loosely correlated
+2.24%
AZTA - SOLV
45%
Loosely correlated
-22.81%
More